Dr. Wang’s Research Published in British Journal of Ophthalmology
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the
read more
Dr. Wang to Speak About Iritis at RheumNow Live! Event
Texas Retina Associates’ Robert C. Wang, MD, will give a presentation on “Iritis and HLA-B27” at the RheumNow Live! event this Sunday, March 21, 2021. RheumNow Live! is an on-site and virtual
read more
Dr. Wang Co-authored Article on New Non-infectious Uveitis Treatment Published in Acta Ophthalmologica Journal
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Management of Repository Corticotropin Injection Therapy for Non‐infectious Uveitis: A Delphi Study” in the March 2021 issue of the medical journal
read more
Dr. Wang Published Article on Long-term Inflammation Control and Uveitis in Retina Today
Texas Retina Associates’ Robert C. Wang, MD, shared three case studies in an article titled “Long-term Inflammation Control Benefits All Types of Uveitis” published in the November/December 2020 issue of the medical
read more
New Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more
Getting to Know Robert C. Wang, MD
Board-certified retina specialist Robert C. Wang, MD, has cared for Texas Retina patients for more than 16 years and currently serves our Dallas Main, Dallas North, Plano and Sherman offices. While he
read more
